Anglo American stock faces key EU test for Brazil nickel sale

Published on 11/09/2026 at 17:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Anglo American stock remains tied to the EU review of its Brazilian nickel sale to MMG. The extended timetable keeps the portfolio decision in focus.

Regulatory deadline remains decisive

Anglo American and MMG extended the Brazilian nickel transaction deadline to December 31, 2026.
The European Commission is expected to decide on the deal by December 21, 2026.
The sale remains conditional on regulatory clearance and could affect Anglo American's portfolio plans.

Anglo American, GB00BTK05J60, Illustration mit AI erstellt.

Anglo American stock traded at 46.64 euros on Lang & Schwarz at 17:46 CET on Monday, November 9, 2026, 4.80 percent above the Xetra close of Friday, November 6. The quote was 45.66 euros in the relevant November 9 report at 10:30 CET, making the later level 2.15 percent higher.

Nickel sale faces EU decision

Anglo American and MMG moved the long-stop date for their proposed Brazilian nickel transaction from October 31 to December 31, 2026. The European Commission is conducting an in-depth Phase II investigation and is expected to issue its decision by December 21.

The Canadian Mining Journal reported on November 3 that the transaction is valued at 500 million US dollars and covers two operating ferronickel businesses and two greenfield projects in Brazil.

Regulatory risk shapes portfolio plans

The European review focuses on whether MMG could redirect Brazilian ferronickel away from European stainless steel producers, potentially weakening competition and supply resilience. MMG has offered guarantees intended to maintain supplies to European customers and said it will continue working with Anglo American and the European Union during the review.

The deadline extension keeps the transaction alive but does not constitute approval or completion. Anglo American has indicated that it could close the Brazilian nickel operation if regulators block the acquisition, leaving the company with a different path for the assets and no planned transaction proceeds.